Literature DB >> 8437849

Different structural organization of Ras and Rho effector domains.

A J Self1, H F Paterson, A Hall.   

Abstract

Ras regulates proliferation and differentiation signals in cells, and activation of the protein can lead to malignant transformation. Activation of the related protein, Rho, affects cell morphology, and it has been suggested that it may also have some oncogenic potential. We show here that Rho does not induce a malignant phenotype in NIH3T3 cells but instead is a potent activator of actin stress fibre formation. The limited homology between Ras and Rho has enabled us to determine the amino acids specifying their different biological activities and GTPase-activating protein (GAP) protein sensitivities using chimeras. Rho substituted with amino acids 23-46 of Ras induces transformed foci in NIH3T3 monolayers, and we conclude that Ras has a single effector domain required for downstream signalling. Although mutational analysis of Rho has revealed that residues 32-42 are also essential for its biological activity, Ras substituted with amino acids 25-48 of Rho does not induce actin stress fibre formation. On the basis of these experiments, we propose that Rho may have two effector domains: one at amino acids 32-42 and corresponding to the effector region of Ras and the second located elsewhere in the carboxy-terminal two-thirds of the molecule.

Mesh:

Substances:

Year:  1993        PMID: 8437849

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  29 in total

1.  The insert region of Rac1 is essential for membrane ruffling but not cellular transformation.

Authors:  A E Karnoub; C J Der; S L Campbell
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Functions and functional domains of the GTPase Cdc42p.

Authors:  K G Kozminski; A J Chen; A A Rodal; D G Drubin
Journal:  Mol Biol Cell       Date:  2000-01       Impact factor: 4.138

3.  R-Ras protein inhibits autophosphorylation of vascular endothelial growth factor receptor 2 in endothelial cells and suppresses receptor activation in tumor vasculature.

Authors:  Junko Sawada; Fangfei Li; Masanobu Komatsu
Journal:  J Biol Chem       Date:  2015-02-02       Impact factor: 5.157

4.  Oncogenic Ras activation of Raf/mitogen-activated protein kinase-independent pathways is sufficient to cause tumorigenic transformation.

Authors:  R Khosravi-Far; M A White; J K Westwick; P A Solski; M Chrzanowska-Wodnicka; L Van Aelst; M H Wigler; C J Der
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

5.  Cdc42 regulates anchorage-independent growth and is necessary for Ras transformation.

Authors:  R G Qiu; A Abo; F McCormick; M Symons
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

6.  The PRK2 kinase is a potential effector target of both Rho and Rac GTPases and regulates actin cytoskeletal organization.

Authors:  S Vincent; J Settleman
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

7.  R-Ras and Rac GTPase cross-talk regulates hematopoietic progenitor cell migration, homing, and mobilization.

Authors:  Xun Shang; Jose A Cancelas; Lina Li; Fukun Guo; Wei Liu; James F Johnson; Ashley Ficker; Deidre Daria; Hartmut Geiger; Nancy Ratner; Yi Zheng
Journal:  J Biol Chem       Date:  2011-05-13       Impact factor: 5.157

8.  Rho and Rab small G proteins coordinately reorganize stress fibers and focal adhesions in MDCK cells.

Authors:  H Imamura; K Takaishi; K Nakano; A Kodama; H Oishi; H Shiozaki; M Monden; T Sasaki; Y Takai
Journal:  Mol Biol Cell       Date:  1998-09       Impact factor: 4.138

9.  Constitutively active RhoA inhibits proliferation by retarding G(1) to S phase cell cycle progression and impairing cytokinesis.

Authors:  Pierre Morin; Cristina Flors; Michael F Olson
Journal:  Eur J Cell Biol       Date:  2009-06-09       Impact factor: 4.492

10.  Aberrant function of the Ras-related protein TC21/R-Ras2 triggers malignant transformation.

Authors:  S M Graham; A D Cox; G Drivas; M G Rush; P D'Eustachio; C J Der
Journal:  Mol Cell Biol       Date:  1994-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.